KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $0.96.

  • Emergent BioSolutions' EPS (Basic) fell 5555.56% to $0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.42, marking a year-over-year increase of 13613.23%. This contributed to the annual value of -$3.6 for FY2024, which is 7578.3% up from last year.
  • Emergent BioSolutions' EPS (Basic) amounted to $0.96 in Q3 2025, which was down 5555.56% from -$0.22 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' EPS (Basic) ranged from a high of $3.33 in Q4 2021 and a low of -$5.38 during Q2 2024
  • In the last 5 years, Emergent BioSolutions' EPS (Basic) had a median value of -$0.59 in 2024 and averaged -$0.89.
  • As far as peak fluctuations go, Emergent BioSolutions' EPS (Basic) crashed by 1050000.0% in 2022, and later soared by 63529.41% in 2025.
  • Emergent BioSolutions' EPS (Basic) (Quarter) stood at $3.33 in 2021, then plummeted by 140.22% to -$1.34 in 2022, then surged by 34.2% to -$0.88 in 2023, then skyrocketed by 32.89% to -$0.59 in 2024, then surged by 262.56% to $0.96 in 2025.
  • Its EPS (Basic) was $0.96 in Q3 2025, compared to -$0.22 in Q2 2025 and $1.25 in Q1 2025.